Breaking barriers in haemophilia A care: 1-year real-world experience with emicizumab prophylaxis at civil service hospital, Kathmandu, Nepal

被引：0
|
作者：
Poudyal, Bishesh Sharma [1 ]
Rajbahak, Jagat Man [2 ]
机构：
[1] Civil Serv Hosp, Kathmandu, Nepal
[2] Nepal Hemophilia Soc, Kathmandu, Nepal
来源：
HAEMOPHILIA | 2024年 / 30卷
关键词：
emicizumab; haemophilia A; inhibitors;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-084 (17
引用
收藏
页码：97 / 97
页数：1
相关论文
共 27 条
  • [1] Breaking barriers in haemophilia A care: One-year real-world experience with emicizumab prophylaxis at Civil Service Hospital, Kathmandu, Nepal
    Poudyal, Bishesh Sharma
    Bajracharya, Nikesh
    Paudel, Bishal
    Karki, Bikram
    Acharya, Devendra
    Shrestha, Nripesh Man
    Gelal, Sanjay
    Shrestha, Anima
    Rizal, Laxmi
    Rajbahak, Jagat Lal
    Joshi, Utsav
    Kouides, Peter
    HAEMOPHILIA, 2024,
  • [2] INVASIVE PROCEDURES IN PATIENTS WITH HAEMOPHILIA ON EMICIZUMAB PROPHYLAXIS: REAL-WORLD CLINICAL EXPERIENCE IN SLOVENIA
    Rener, K.
    Pompe, B.
    Doma, S. Anzej
    Kotnik, B. Faganel
    Kitanovski, L.
    Zupan, I. Preloznik
    HAEMOPHILIA, 2022, 28 : 66 - 66
  • [3] Real-world experience of emicizumab prophylaxis in children with severe haemophilia A: I year follow-up study in egypt
    Sherief, L.
    Hassan, A. S.
    Hamdy, M.
    Darwish, A.
    Nazim, A.
    Hussein, M. A.
    Elgendy, M. R.
    El-assy, O. A.
    HAEMOPHILIA, 2024, 30 : 121 - 121
  • [4] Real-world data of prophylaxis with emicizumab in children and adolescents with severe haemophilia: A single centre experience
    Michalopoulou, A.
    Dettoraki, A.
    Karelioti, H.
    Thymianou, S.
    Papageorgiou, N.
    Stamati, I.
    Saslis, S.
    Kapsimali, Z.
    Pergantou, H.
    HAEMOPHILIA, 2024, 30 : 61 - 61
  • [5] Real-world experience of emicizumab prophylaxis in young children with haemophilia A in China: retrospective data from China
    Huang, Kun
    Liu, Guoqing
    Wu, Runhui
    Chen, Zhenping
    Zhen, Yingzi
    Wu, Xinyi
    HAEMOPHILIA, 2022, 28 : 50 - 50
  • [6] Real-world experience on the tolerability and safety of emicizumab prophylaxis in paediatric patients with severe haemophilia A with and without FVIII inhibitors
    Hassan, Eman
    Jonathan, Lancashire
    Jayashree, Motwani
    HAEMOPHILIA, 2021, 27 (06) : E698 - E703
  • [7] Transitioning patients with severe haemophilia A from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: Real-world clinical experience
    Klamroth, Robert
    Gottstein, Saskia
    HAEMOPHILIA, 2024, 30 (05) : 1247 - 1249
  • [8] Risankizumab for the treatment of genital psoriasis: A 1-year, real-world experience
    Orsini, D.
    Frascione, P.
    Assorgi, C.
    Pacifico, A.
    Sperduti, I.
    Gargiulo, L.
    Ibba, L.
    Valenti, M.
    Costanzo, A.
    Narcisi, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (03) : e256 - e258
  • [9] Management of people with haemophilia A undergoing surgery while receiving emicizumab prophylaxis: Real-world experience from a large comprehensive treatment centre in the US
    Lewandowska, Magdalena
    Randall, Nicole
    Bakeer, Nihal
    Maahs, Jennifer
    Sagar, Jeanne
    Greist, Anne
    Shapiro, Amy D.
    HAEMOPHILIA, 2021, 27 (01) : 90 - 99
  • [10] Transapical Mitral Valve Replacement 1-Year Results of the Real-World Tendyne European Experience Registry
    Hell, Michaela M.
    Wild, Mirjam G.
    Baldus, Stephan
    Rudolph, Tanja
    Treede, Hendrik
    Petronio, Anna Sonia
    Modine, Thomas
    Andreas, Martin
    Coisne, Augustin
    Duncan, Alison
    Franco, Luis Nombela
    Praz, Fabien
    Ruge, Hendrik
    Conradi, Lenard
    Zierer, Andreas
    Anselmi, Amedeo
    Dumonteil, Nicolas
    Nickenig, Georg
    Pinon, Miguel
    Barth, Sebastian
    Adamo, Marianna
    Dubois, Christophe
    Torracca, Lucia
    Maisano, Francesco
    Lurz, Philipp
    von Bardeleben, Ralph Stephan
    Hausleiter, Joerg
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (05) : 648 - 661
123